Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Switching between GLP-1RA medications should be viewed as a normal part of long-term obesity care, said senior author Sarah Messiah, Ph.D., M.P.H., Professor of Epidemiology and Pediatrics, Associate Dean for Research in the ODonnell School of Public Health, and Director of the Child and Adolescent Population Health Program
Patient Education : Patients should be educated about the signs and symptoms of potential adverse effects, such as severe nausea, signs of pancreatitis (e.g., severe abdominal pain), or symptoms of serotonin syndrome (e.g., rapid heart rate, hallucinations)
Payment warning: Consultation fees are generally non-refundable after provider review
Test subjects were included in the study if they were at least 18 years of age with a type 2 diabetes diagnosis and stable treatment with metformin, thiazolidinediones, and/or sulfonylureas, for at least 90 days prior to the initiation of the experiment
Guilford Press 2010
US$ 29.10
US$ 26.11
US$ 21.32
US$ 25.55
US$ 26.71
US$ 21.48
US$ 22.55
US$ 23.86
